Lytenava
RxNorm concept 2749112, brand name (bn).
- RxCUI
- 2749112
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2749112 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- bevacizumab-vikg (PIN, has precise ingredient)
- bevacizumab-vikg 25 MG/ML [Lytenava] (SBDC, ingredient of)
- Lytenava Injectable Product (SBDG, ingredient of)
- bevacizumab Injection [Lytenava] (SBDF, ingredient of)
- 0.05 ML bevacizumab-vikg 25 MG/ML Injection [Lytenava] (SBD, ingredient of)
- bevacizumab (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2749112 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2749112 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2749112. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.